Developing Antiviral Therapies Targeting Host Factors
Author Information
Author(s): Andrew Prussia, Pahk Thepchatri, James P. Snyder, Richard K. Plemper
Primary Institution: Emory University
Hypothesis
Can targeting host factors instead of pathogens reduce viral resistance and improve antiviral therapy effectiveness?
Conclusion
Host-directed antiviral therapies show promise in overcoming viral resistance by targeting essential host factors.
Supporting Evidence
- Targeting host factors may prevent the rapid development of viral resistance.
- Host-directed therapies could broaden the range of pathogens that can be treated with a single drug.
- Bioinformatics can help identify potential gene targets for antiviral therapies.
Takeaway
This study suggests that instead of attacking viruses directly, we can block the things in our cells that viruses need to survive, which might help stop them from becoming resistant to treatments.
Methodology
The study reviews various bioinformatics approaches and experimental strategies to identify host factors essential for viral replication.
Potential Biases
There is a risk of bias due to the variability in experimental conditions and methodologies across different studies.
Limitations
The study highlights the variability in results from different RNAi screens and the potential for false positives in identifying host factors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website